Indian CV case peaked unprecedentedly & their vaccine P3 efficacy data says 78%. Their US distribution partner stock soared dispite their product,even with FDA approval in future, no longer will be really needed in this country. Interesting...
Indian CV case peaked unprecedentedly & their vaccine P3 efficacy data says 78%. Their US distribution partner stock soared dispite their product,even with FDA approval in future, no longer will be really needed in this country. Interesting...
Comments